OBJECTIVE: The aldosterone-renin ratio (ARR) is widely used to screen for primary aldosteronism, and may reflect a relative excess of aldosterone secretion compared with renin secretion. Excess aldosterone may have a detrimental effect on vascular stiffness. We therefore hypothesized that ARR and aldosterone are independently correlated with pulse wave velocity (PWV) in hypertensive patients. METHODS: The study consisted of 438 hypertensive patients. Serum aldosterone and plasma renin activity were measured in a sitting position using standard techniques. The PWV was determined by measuring the heart to femoral PWV (hfPWV) and brachial to ankle PWV with a VP-2000 pulse wave unit. RESULTS: Group 1 was defined as patients with ARR of at least 20 (n = 53) with serum aldosterone >or= 12 ng/dl, while the remainder comprised group 2. Comparisons between the two groups reveal group 1 tended to have higher age, significantly higher proportion of women and higher systolic/diastolic blood pressure. Patients in group 1 also had a significantly higher index of central arterial stiffness (hfPWV 1048 +/- 202 vs 978 +/- 182, P = 0.010) compared with group 2. Multiple linear regression revealed that aldosterone, but not the ARR, is significantly associated with hfPWV but not brachial to ankle PWV, after controlling for age, systolic blood pressure and heart rate at the time of PWV measurement, body mass index, gender, low-density lipoprotein-cholesterol, triglyceride, high-density lipoprotein-cholesterol, blood pressure medication and statins. CONCLUSIONS: Serum aldosterone is significantly associated with central aortic PWV in hypertensive patients. The results demonstrate a possible role for aldosterone in developing central aortic stiffness and increased PWV in hypertensive patients.
OBJECTIVE: The aldosterone-renin ratio (ARR) is widely used to screen for primary aldosteronism, and may reflect a relative excess of aldosterone secretion compared with renin secretion. Excess aldosterone may have a detrimental effect on vascular stiffness. We therefore hypothesized that ARR and aldosterone are independently correlated with pulse wave velocity (PWV) in hypertensivepatients. METHODS: The study consisted of 438 hypertensivepatients. Serum aldosterone and plasma renin activity were measured in a sitting position using standard techniques. The PWV was determined by measuring the heart to femoral PWV (hfPWV) and brachial to ankle PWV with a VP-2000 pulse wave unit. RESULTS: Group 1 was defined as patients with ARR of at least 20 (n = 53) with serum aldosterone >or= 12 ng/dl, while the remainder comprised group 2. Comparisons between the two groups reveal group 1 tended to have higher age, significantly higher proportion of women and higher systolic/diastolic blood pressure. Patients in group 1 also had a significantly higher index of central arterial stiffness (hfPWV 1048 +/- 202 vs 978 +/- 182, P = 0.010) compared with group 2. Multiple linear regression revealed that aldosterone, but not the ARR, is significantly associated with hfPWV but not brachial to ankle PWV, after controlling for age, systolic blood pressure and heart rate at the time of PWV measurement, body mass index, gender, low-density lipoprotein-cholesterol, triglyceride, high-density lipoprotein-cholesterol, blood pressure medication and statins. CONCLUSIONS: Serum aldosterone is significantly associated with central aortic PWV in hypertensivepatients. The results demonstrate a possible role for aldosterone in developing central aortic stiffness and increased PWV in hypertensivepatients.
Authors: Jennifer N Cooper; Ping Tepper; Emma Barinas-Mitchell; Genevieve A Woodard; Kim Sutton-Tyrrell Journal: Clin Exp Hypertens Date: 2011-10-18 Impact factor: 1.749
Authors: S R Collier; K Sandberg; A M Moody; V Frechette; C D Curry; H Ji; R Gowdar; D Chaudhuri; M Meucci Journal: J Hum Hypertens Date: 2014-05-01 Impact factor: 3.012
Authors: Wolfgang Lieb; Martin G Larson; Emelia J Benjamin; Xiaoyan Yin; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Thomas J Wang; Joseph A Vita; Daniel Levy; Ramachandran S Vasan; Gary F Mitchell Journal: Circulation Date: 2008-12-22 Impact factor: 29.690
Authors: Lee Stoner; Michelle L Meyer; Anna Kucharska-Newton; Keeron Stone; Gabriel Zieff; Gaurav Dave; Simon Fryer; Daniel Credeur; James Faulkner; Kunihiro Matsushita; Timothy M Hughes; Hirofumi Tanaka Journal: J Hypertens Date: 2020-09 Impact factor: 4.844
Authors: Jung Eun Lee; Hyung Jong Kim; Sung Jin Moon; Ji Sun Nam; Jwa-Kyung Kim; Seung Kyu Kim; Gi Young Yun; Sung Kyu Ha; Hyeong Cheon Park Journal: Korean J Intern Med Date: 2013-10-29 Impact factor: 2.884